MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BridgeBio Pharma (BBIO) Ownership - Who owns BridgeBio Pharma?

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
839
Web
https://www.bridgebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.49B
P/E Ratio
N/A
Total Cash
940.19M
Projected Growth
N/A
Total Debt
2.49B
Revenue
579.96M
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
4.80
Total Debt/Equity
N/A
Revenue/Share
3.01 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BBIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BBIO
A.I. Advisor
published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
839
Web
https://www.bridgebio.com